BioTech

Foamix Pharmaceuticals Ltd. received U.S. Food and Drug Administration (FDA) approval for its  AMZEEQTM (minocycline) topical foam, 4%. AMZEEQ, provides treatment for inflammatory lesions caused by non-nodular moderate to severe acne vulgaris in adults and pediatric patients (age 9 and older). This...

Teva Pharmaceutical received excellent news today, when it was reported the company had reached a tentative agreement with the State of Ohio for its part in the Opioid crisis. The settlement was for $10 million, a sum much below the expectations of...

Teva, once the flagship company of the Israeli economy, has had more woes than the prophet Job. Despite its many problems, Teva still has a strong core business and hopes that by cutting enough expenses from its operations it can become profitable...

Teva Pharmaceutical has entered into a settlement with the State of Oklahoma over the company's marketing of Opioid drugs. Although Teva has not admitted any wrongdoing, it has agreed to pay a fine of $85 million to settle all outstanding claims against...

Todos Medical Ltd. a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, such as Alzheimer's disease, today announced that it has received approval from the Israeli Ministry of Health (AMAR) to...

Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of Tarceva®1 (erlotinib) tablets, 100 and 150 mg, in the U.S. Erlotinib Tablets are a kinase inhibitor indicated for the treatment of patients with metastatic non-small cell lung...